Akiyo Yoshimura
13PUBLICATIONS
34CO-AUTHORS

Get your video featured.

Get your video featured.
Publications (13)
Sort by Publication Date:
|Jan 09, 2025
Trastuzumab-Pertuzumab Plus Eribulin or Taxane as First-Line Chemotherapy for Human Epidermal Growth Factor 2-Positive Locally Advanced/Metastatic Breast Cancer: The Randomized Noninferiority Phase III EMERALD Trial.Toshinari Yamashita, Shigehira Saji, Toshimi Takano
|Jan 01, 2025
Supraclavicular Irradiation Induces Lymphedema in Breast Cancer Patients Treated with Axillary Lymph Node Dissection and Taxane-Containing Chemotherapy.Nanae Horisawa, Akiyo Yoshimura, Isao Oze
|Sep 12, 2024
Safety of a short-term infusion of fosnetupitant in patients with gastrointestinal and breast cancer: a prospective study.Akinobu Nakata, Naoya Hashimoto, Yukiya Narita
|May 26, 2024
Clinical benefit of post-trastuzumab deruxtecan treatment in patients with HER 2-positive unresectable or metastatic breast cancer: A single-institution retrospective observational study.Ayaka Isogai, Kazuki Nozawa, Akira Nakakami
|Apr 13, 2023
Evaluation of the Role of Axillary Lymph Node Fine-Needle Aspiration Cytology in Early Breast Cancer With or Without Neoadjuvant Chemotherapy.Daiki Takatsuka, Akiyo Yoshimura, Masataka Sawaki
Pageof 3
Frequent Collaborators
6 joint publications
Hiroji Iwata
5 joint publications
Yuka Endo
5 joint publications
Masataka Sawaki
4 joint publications
Masaya Hattori
4 joint publications
Haruru Kotani
4 joint publications
Ayumi Kataoka
4 joint publications
Yuri Ozaki
4 joint publications
Kazuki Nozawa
3 joint publications
Ayaka Isogai
3 joint publications
Nanae Horisawa